Immortalization of human primary B lymphocytes in vitro with DNA
The DOI matches its Crossref record.
Abstract
Epstein-Barr virus (EBV) is a human DNA tumor virus that efficiently immortalizes human primary B lymphocytes in vitro. Although viral genes that are expressed in latently infected B lymphocytes have been shown to function in cellular growth control, their detailed genetic analysis has been cumbersome for two reasons. The viral genome is too large to permit genetic engineering and human primary B lymphocytes, the only targets for infection by EBV in vitro, are both intractable in culture and recalcitrant to DNA transfection. To overcome these obstacles, we have assembled all the essential genes of EBV on a single recombinant vector molecule in Escherichia coli. We show here that this mini-EBV plasmid can yield immortalized B cells upon transfer of its naked DNA into human primary B lymphocytes. Established cell lines carry recombinant vector DNA and cannot support virus production. Because this DNA can be easily manipulated in E. coli, mutant mini-EBVs as well as foreign genes can now be introduced and studied successfully in recipient B lymphocytes from any human donors. These mini-EBVs therefore are potentially useful for human gene therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Transfection of DNA is extremely inefficient [11] and gene vectors based on retroviruses, lentiviruses or adenoviruses reach transduction rates of <1% in these cells even when we follow published protocols [12,13].”
From Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection (2021) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Kilger, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1700 · Cited by 483
Propagation and recovery of intact, infectious Epstein–Barr virus from prokaryotic to human cells
Delecluse, H.-J., Hilsendegen, T., Pich, D., Zeidler, R., & Hammerschmidt, W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8245 · Cited by 467
Self-citationKieser, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.21.6478 · Cited by 319
Sutkowski, N., Chen, G., Calderon, G., & Huber, B. T. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7852-7860.2004 · Cited by 98
Akidil, E., Albanese, M., Buschle, A., Ruhle, A., Pich, D., Keppler, O. T., & Hammerschmidt, W. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009117 · Cited by 31
Self-citation
Metadata
- Authors
- Kempkes, B., Pich, D., Zeidler, R., & Hammerschmidt, W.
- Affiliations
- Institut für Klinische Molekularbiologie und Tumorgenetik, GSF-Forschungszentrum für Umwelt und Gesundheit GmbH, Munich, Germany.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1995-06-20
- Volume
- 92
- Issue
- 13
- Pages
- 5875-5879
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 40
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immortalization of human primary B lymphocytes in vitro with DNA. https://app.cochat.ai/papers/10.1073/pnas.92.13.5875
- The paper
- Kempkes, B., Pich, D., Zeidler, R., & Hammerschmidt, W. (1995). Immortalization of human primary B lymphocytes in vitro with DNA. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.92.13.5875
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.